Claire Edgerton Susie Diacopoulos Crop

Greater than the sum of its parts – Omnichannel insights from two industry experts

Even though Pfizer’s customers prefer face-to-face, most of their engagement is digital, writes Clifford Fram, director of partnerships and innovation at adg. Claire Edgerton’s morning fix is to check the data. She likes to know what content and channels Pfizer’s customers are engaging with – what they’re reading, what they’re watching and what they’re searching


Infographic 8 Tips For Engaging Busy Doctors Featured Image Resize

8 Tips for Engaging Busy Doctors with your Digital Content

The digital revolution has had a significant positive impact on how doctors’ access pharmaceutical information, especially in the post-COVID-19 era. This has ultimately enhanced the quality use of medicines and patient care. More recently, with the ubiquitous use of the word ’omnichannel’, the short-term challenge for pharma is finding the right mix between traditional face-to-face


Article 2 Asian Woman Reading Report

AusDoc survey uncovers top 5 pathology-led GP education opportunities

A recent AusDoc survey of 418 GPs and GP registrars focusing on pathology tests has uncovered a raft of unmet needs for GP education, and opened up a range of opportunities for pathology organisations and pharma companies to offer meaningful med ed. Respondents were crying out for further education, with several key areas of particular


GP Study on Pathology Testing and Patient Insights - Tubes Image

AusDoc survey puts GPs’ pathology testing views under the microscope

Pathology testing and the interpretation of results are regular challenges for many GPs, and there are several key areas that are particularly problematic, an AusDoc survey of 418 GPs and GP registrars has revealed. 1. Ordering tests: vague symptoms pose problems When it comes to deciding which pathology tests to order, the clinical presentations that


Readership Survey Charts V2 150ppi 1

GPs vote AusDoc #1 in Print, Online & Newsletters

GP Readership Survey of Independent Australian Medical Publications (November 2023) A survey of more than 330 Australian GPs has once again confirmed the reach and influence of independent medical publications as being critically important for any organisation looking to communicate with doctors1.    The survey run by AusDoc was shared with 26,000 AHPRA verified GPs, with more


Healthcare Marketing - right content type for your campaign

5 ways to choose the right content type for your campaign

Have you ever wondered which type of content will work best for your campaign? If so, you’re not alone. It’s one of the most frequently asked questions AusDoc receives from marketers and agencies. The key to success is to think like a journalist, says Amanda Davey, AusDoc Commercial Content Editor and the former editor of


Growth Frequency 03

How increasing message frequency led to a +14% growth in prescribing

Whether it be the original ‘Rule of 7’or more recent studies that suggest the new number is much higher in the digital age we now live in, the premise remains that increasing message frequency can have a significant impact on retention and driving behaviour change, but does this theory extend to doctors? Let’s start with


Rsz Ih Solus Edm

How a solus eDM helped a pharma brand to quickly regain lost market share following negative publicity

A leading prescription brand had lost market share following negative publicity. With local key opinion leaders questioning the brand’s efficacy, both medical and consumer media were running hard with the story – eroding prescriber and patient trust. The client needed a powerful tool to support its omnichannel response and quickly turn this around.


Rsz Mc Article 1

Exclusive AusDoc survey: Understanding doctors’ perceptions and behaviours regarding medicinal cannabis 

Exclusive AusDoc survey. What you will learn from reading this article:   Doctors are experiencing increased patient demand for medicinal cannabis, but most acknowledge a lack of knowledge about risks and benefits and are unsure how to advise patients, says a 2021 meta-analysis of 21 international articles. Fast-forward to 2023 and not much has changed, according